News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication Feb 25, 2022 A Nonparametric Approach to Confidence Intervals for Concordance Index and Difference Between Correlated Indices Guangyong Zou, Vipul Jairath Read Now
Publication Feb 23, 2022 Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Eileen Crowley, Vipul Jairath Read Now
Publication Feb 19, 2022 Sphingosine 1-Phosphate Modulation and Immune Cell Trafficking in Inflammatory Bowel Disease ATRC, Niels Vande Casteele Read Now
Publication Feb 15, 2022 Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn’s Disease: Systematic Review and Meta-Regression Christopher Ma, Guangyong Zou, Rocio Sedano, Stefanie C McFarlane, Vipul Jairath Read Now
Publication Feb 9, 2022 Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn’s Disease Brian Feagan, Christopher Ma, Geert D’Haens, Guangyong Zou, Jordi Rimola, Vipul Jairath Read Now
Publication Feb 1, 2022 Reliability and Responsiveness of Endoscopic Disease Activity Assessment in Eosinophilic Esophagitis Arjan Bredenoord, Brian Feagan, Christopher Ma, Evan Dellon, Guangyong Zou, Julie Rémillard, Malcolm Hogan, Vipul Jairath Read Now
